Boston University and RayVio Expand Research to Combat the World's Most Common Medical Condition: Vitamin D Deficiency
HAYWARD, Calif., July 26, 2016 /PRNewswire/ -- RayVio Corp., an advanced health and hygiene company, today announced it is expanding a research program with Boston University to develop new treatments for vitamin D deficiency, a disorder associated with osteoporosis, rickets and other metabolic bone diseases. The research, being led by Dr. Michael F. Holick, will expose various skin samples to UV light generated by RayVio's LEDs to determine appropriate exposure times and intensity that can be effectively and safely used to treat vitamin D deficiency disorders.
"Vitamin D deficiency affects more than 100 million Americans and over a billion people worldwide," said Dr. Michael F. Holick, Ph.D., M.D., Professor of Medicine, Physiology and Biophysics at Boston University School of Medicine, an endocrinologist at Boston Medical Center and lead researcher on the study. "Finding a solution will reduce the onset of catastrophic illnesses and potentially saves hundreds of thousands of lives."
"Our previous work with RayVio demonstrated that very low intensity UV light from LEDs – the kind that might be incorporated into today's wearable technologies – will boost vitamin D production in skin and can improve peoples' health," continued Dr. Holick. "Our new program expands on that work to determine the best wavelength of light, appropriate duration and intensity that will optimize new and more effective treatments."
Vitamin D deficiency leads to debilitating diseases like osteoporosis, rickets and even increases the risk of developing common deadly cancers, diabetes, autoimmune diseases including multiple sclerosis and heart disease. Studies have also shown links between vitamin D deficiency and brain disorders including and Alzheimer's disease, depression and schizophrenia.
"At RayVio, we can produce LEDs targeted to specific wavelengths, and working with Dr. Holick and his team will allow us to mass produce LEDs that provide the optimum UV light and intensity to address vitamin D deficiency," said Robert C. Walker, Ph.D., CEO of RayVio.
The results from earlier trials conducted by Dr. Holick and the RayVio team are available upon request. Those wishing to receive ongoing updates about the research and summary results of the expanded program can register here to receive them.
In addition to the joint research project with Dr. Holick, RayVio's latest deep UV LEDs are being applied to disinfection and water purification applications that have the potential to reduce hospital acquired infections and illnesses that result from drinking unsafe water.
About RayVio Corp.
RayVio Corp. is an advanced health and hygiene company that delivers clean water and environments. RayVio helps protect billions from germs and creates new markets and revenue streams by enabling a new class of products. Its powerful and efficient UV LED technology can be integrated into a variety of applications, powering versatile on-demand solutions that give consumers control over health without chemicals or costly consumables. To learn more, please visit www.rayvio.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/boston-university-and-rayvio-expand-research-to-combat-the-worlds-most-common-medical-condition-vitamin-d-deficiency-300303689.html
SOURCE RayVio Corp.